In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Basilea Pharmaceutica raises CHF205.8mm with IPO

Executive Summary

Basilea Pharmaceutica Ltd. (develops antibacterial, antifungal, and dermatological therapeutics) raised CHF205.8mm ($161.2mm) with an IPO of 2.1mm shares priced at CHF98 on the Swiss SWX market. The company's proposed price range when it filed earlier this month was CHF90-115; it originally sought to raise CHF189-241.5mm.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies